Why Is Corvus Pharmaceuticals Stock Trading Lower On Wednesday?
  • December 18, 2024

Why Is Corvus Pharmaceuticals Stock Trading Lower On Wednesday?

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) released interim data from a Phase 1 trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis. The trial will enroll 64 patients with moderate to severe atopic dermatitis who previously failed one prior topical or systemic therapy. These doses were selected based on the company’s prior experience evaluating soquelitinib in T-cell lymphoma patients. The company is reporting complete results from Cohort 1 of the trial, which inc

Freight market shows additional signs of recovery
  • December 18, 2024

Freight market shows additional signs of recovery

Tender rejection rate rises as holidays approach The tender rejection rate has risen steadily since early October despite tender volume declining. That implies that capacity is leaving the market, which […] The post Freight market shows additional signs of recovery appeared first on FreightWaves.

S&P 500 buyers step in ahead of Fed meet despite narrow breadth
  • December 18, 2024

S&P 500 buyers step in ahead of Fed meet despite narrow breadth

(Bloomberg) -- While concern has grown in the past week that narrowing market breadth has tapped the brakes on the S&P 500 Index’s blistering rally, it turns out that stock bulls are still stepping in to snap up shares ahead of the Federal Reserve’s interest-rate decision.Most Read from BloombergHow California Sees the World, and ItselfThe index’s DVAN trend line — a proprietary divergence analysis that measures buying or selling pressure — has been on a buying streak since Election Day, with in

Analysis: Macro a must-have for hedge fund investors betting on 2025 market swings
  • December 18, 2024

Analysis: Macro a must-have for hedge fund investors betting on 2025 market swings

Next year's top pick for hedge fund strategies is so-called macro, with U.S. President-elect Donald Trump centre-stage as investors bet on how global policy decisions will impact economic conditions and play out in financial markets. Hedge fund returns benefited this year from wild market swings sparked by politics such as November's U.S. election, and twists in monetary policy such as Bank of Japan rate hikes. And investors are readying for more volatility in the year ahead, seven hedge fund investors and portfolio managers told Reuters and a recent survey showed.

What's Going On With Viking Therapeutics Stock On Wednesday?
  • December 18, 2024

What's Going On With Viking Therapeutics Stock On Wednesday?

On Wednesday, Merck & Co Inc (NYSE:MRK) and Hansoh Pharma, a Chinese biopharmaceutical company, entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist. Under the agreement, Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture, and commercialize HS-10535. Hansoh Pharma will receive an upfront payment of $112 million and is eligible to receive up to $1.9 billion in milestone payments

A 1130% Share Price Rally Draws Questions From Brazil’s Stock Exchange Operator
  • December 18, 2024

A 1130% Share Price Rally Draws Questions From Brazil’s Stock Exchange Operator

(Bloomberg) -- A whopping 1130% rally in the shares of a Brazilian waste management company is drawing the attention of the country’s stock exchange operator. Most Read from BloombergNYPD Car Chases Are Becoming More Frequent — and More DangerousB3 SA, the company behind Brazil’s stock exchange, requested clarification on “atypical fluctuations” in the shares of Ambipar Participacoes e Empreendimentos SA that took place between Dec. 11 and 13, according to a note. On those days, the stock surged